ME Therapeutics Holding (XCNQ:METX) Total Current Assets : C$1.36 Mil (As of Feb. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. ME Therapeutics Holding's total current assets for the quarter that ended in Feb. 2024 was C$1.36 Mil.

ME Therapeutics Holding Total Current Assets Historical Data

The historical data trend for ME Therapeutics Holding's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Total Current Assets Chart

ME Therapeutics Holding Annual Data

Trend

Aug22

Aug23

Total Current Assets

0.10

0.67

ME Therapeutics Holding Quarterly Data
	Aug22	Dec22	May23	Aug23	Nov23	Feb24
Total Current Assets	Get a 7-Day Free Trial			0.77	0.64	0.67	0.47	1.36

ME Therapeutics Holding Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

ME Therapeutics Holding's Total Current Assets for the fiscal year that ended in Aug. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.647	+	0.007	+	0	+	0.018
	=	0.67

ME Therapeutics Holding's Total Current Assets for the quarter that ended in Feb. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.347	+	0.008	+	0	+	0.008
	=	1.36

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

ME Therapeutics Holding (XCNQ:METX) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

ME Therapeutics Holding's Liquidation Value for the quarter that ended in Feb. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.347	-	0	+	0.75 * 0	+	0.5 * 0
=	1.35

ME Therapeutics Holding Total Current Assets Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

Q9T:Germany

Address

177 Robson Street, Vancouver, BC, CAN, V6B 0N3

Website

https://www.metherapeutics.com

ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines